Brief: Cytodyn Says Will Attempt To Duplicate Berlin And London Patients’ HIV Cure
Aug 17 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN WILL ATTEMPT TO DUPLICATE BERLIN AND LONDON
PATIENTS’
HIV CURE BY USING LERONLIMAB DURING BONE MARROW TRANSPLANT FOR 5
HIV PATIENTS WHO ALSO HAVE CANCER
* CYTODYN INC - NOW HAVE FOUR PATHS FORWARD FOR USE OF
LERONLIMAB
IN HIV INDICATION FOR DIFFERENT POPULATIONS
Source text for Eikon: ID:nGNX69Zz0y
Further company coverage: CYDY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer